SEC Filing Analysis: DarioHealth Corp. (DRIO)

Executive Summary

• Trading Significance: High
• Key Takeaway: Craig Kallman, via the Craig Kallman 2015 Living Trust, has disclosed a new 9.99% beneficial ownership stake in DarioHealth Corp., a significant position in the small-cap medical device company.
• Market Impact: The establishment of a new, large passive stake is a significant event that can be viewed positively by the market as a vote of confidence.

Company Information

Field	Value
Company	DarioHealth Corp.
Ticker Symbol	DRIO
CIK	0001533998
Industry	Surgical & Medical Instruments & Apparatus

Filer Information

Field	Value
Name	Craig Kallman
CIK	0002101421
Title/Position	Trustee, Craig Kallman 2015 Living Trust
Relationship	Beneficial Owner of more than 5%

Holding Details

Field	Value
Form Type	SCHEDULE 13G
Event Date	2025-09-23
Security Type	Common Stock
Shares Beneficially Owned	675,165
Percent of Class	9.99%
Ownership Type	Indirect (via Trust)

Financial Impact Assessment

Position Materiality

Metric	Value
Approx. Position Value	$7,990,000
% of Market Cap	9.99%
Shares Owned	675,165
% of Shares Outstanding	9.99%
Materiality Assessment	Highly Significant

Note: Position value is estimated based on the company's $80M market cap and the 9.99% ownership stake. Shares outstanding of 6,758,412 is taken directly from the filing.

Impact Evaluation

• Market Cap Context: For a company with an $80 million market capitalization, a single investor taking a nearly $8 million stake is a substantial and highly material event. This represents a significant concentration of ownership.
• Ownership Concentration: This filing establishes Craig Kallman as one of the largest single shareholders in the company. A 9.99% stake carries significant weight and is just below the threshold that would require a more detailed 13D filing for active investors.
• Transaction Significance: The disclosure of a new 9.99% stake is highly significant. It signals a strong conviction from the investor and provides a data point for other market participants about perceived value in the company.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral to Positive
• Reasoning: A Schedule 13G indicates a passive investment purpose, not an intent to influence control. However, the accumulation of such a large stake by a new investor is often interpreted by the market as a bullish signal, suggesting the investor sees the stock as undervalued.

Volume & Sentiment

• Expected Volume Impact: May lead to a near-term increase in trading volume as the market digests the news of a new major shareholder.
• Sentiment Indicator: Bullish. The size of the stake relative to the company's market cap is a strong vote of confidence.

Investment Insights

Positive Market Indicators

• A new, large investor has taken a significant position, suggesting conviction in the company's value or future.
• The stake is substantial (9.99%), making the investor's position highly meaningful.
• The disclosure provides validation for the company's strategy and market position.

Risk Factors

• As a passive filing (13G), the investor does not intend to agitate for change. Future conversion to an active (13D) stance or a sale of the large block of shares could introduce volatility.

Key Takeaways

1. Major New Stakeholder: Craig Kallman is now a major shareholder in DarioHealth with a 9.99% beneficial ownership.
2. High Materiality: The position represents nearly 10% of the company's market capitalization, making it a highly significant event for the small-cap firm.
3. Passive Intent: The Schedule 13G filing signals the stake was not acquired for the purpose of influencing control of the company, which is a less confrontational stance than an activist 13D filing.

Additional Context

Transaction Notes

• The beneficial ownership consists of 604,803 shares of common stock and pre-funded warrants exercisable for 124,031 shares of common stock.
• The ownership percentage is contractually limited to 9.99% as per the terms of the warrants.